Clinical Trial Update: Study of S-1 and Oxaliplatin as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

This entry summarizes a Phase 2 study evaluating S-1 in combination with oxaliplatin as neoadjuvant chemotherapy for locally advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN